Biotech | May 07, 2022
Gut microbiome as a tool in regenerative medicine
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
The drug will be manufactured at the group's formulation facility at SEZ, Ahmedabad
This agreement is truly remarkable for achieving greater objectives in the projects and addressing larger problems
The research was funded by the National Institutes of Health, the Eversight Center for Vision and Eye Banking Research, and Research to Prevent Blindness
The facility is among 12 centres established worldwide, and the first in Asia
The companies expect to complete the submission of the NDA for treatment of MDD in the second half of 2022; associated filing for postpartum depression is anticipated in the first half of 2023
Move brings together AstraZeneca and Alexion colleagues in a purpose-built facility in Kendall Square, Cambridge, MA, a world-leading life sciences hub
Onshore manufacturing facility is expected to be based in Quebec and produce up to 100 million mRNA respiratory vaccine doses annually
Glenmark Pharmaceuticals won Innovation of the Year award
University of Pennsylvania scientists Katalin Karikó and Drew Weissman to be honoured at June 7 symposium in New York City for their research that enabled Covid-19 vaccines
Subscribe To Our Newsletter & Stay Updated
